Dumping Syndrome

15 registered clinical trials studyying Dumping Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome NCT07440706	Kaiser Clinic and Hospital	N/A
Active Not Recruiting	Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipar NCT07263269	Mina Kamal Gergis Erian	N/A
Recruiting	Dumping Syndrome and Esophageal Atresia NCT04522193	University Hospital, Lille	N/A
Completed	Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypa NCT05057819	Insel Gruppe AG, University Hospital Bern	Phase 4
Unknown	Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery NCT05759689	Larissa University Hospital	N/A
Unknown	Fat Supplementation on Dumping Syndrome Associated Symptoms NCT04028193	Technological Educational Institute of Thessaly	N/A
Completed	Gastrectomy, Eating Behaviour and GLP-1 NCT02971631	Cambridge University Hospitals NHS Foundation Trust	N/A
Completed	Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for O NCT02891330	University Hospital, Lille	N/A
Terminated	Metabolic Consequences of Gastrointestinal Surgery NCT02836353	Cambridge University Hospitals NHS Foundation Trust	N/A
Completed	Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery NCT03734627	St. James's Hospital, Ireland	—
Completed	Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored NCT01794793	RECORDATI GROUP	Phase 4
Completed	Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndro NCT01637272	Novartis Pharmaceuticals	Phase 2
Completed	Dumping Syndrome After Operation of Esophageal Atresia Type III NCT02525705	University Hospital, Lille	N/A
Completed	SOMATULINE Autogel 90 mg IN DUMPING SYNDROME NCT01923649	Universitaire Ziekenhuizen KU Leuven	Phase 2
Unknown	Treatment of the Dumping Syndrome With Lanreotide Autogel® NCT00543179	Radboud University Medical Center	Phase 4